Global Markets and Technologies for Advanced Drug Delivery Systems
상품코드:1423537
리서치사:BCC Research
발행일:2024년 02월
페이지 정보:영문 265 Pages
라이선스 & 가격 (부가세 별도)
한글목차
세계 첨단 약물전달 시스템 시장 규모는 2023년 2,626억 달러에서 예측 기간 동안 6.5%의 CAGR을 기록하며 2028년 말에는 3,591억 달러 규모로 성장할 것으로 예상됩니다.
북미 시장은 2023년 1,094억 달러에서 연평균 6.8% 성장하여 2028년 말에는 1,521억 달러 규모로 성장할 것으로 예측됩니다. 아시아태평양 시장은 2023년 477억 달러에서 연평균 7.5% 성장해 2028년 말에는 686억 달러 규모로 성장할 것으로 예상됩니다.
세계 첨단 약물전달 시스템 시장을 조사했으며, 시장 개요, 시장 영향요인 및 시장 기회 분석, 시장 규모 추이 및 예측, 각 부문별·지역별 상세 분석, 임상시험 및 특허 동향, 경쟁 상황, 주요 기업 개요 등의 정보를 정리하여 전해드립니다.
목차
제1장 서론
제2장 요약과 하이라이트
시장 전망
시장 하이라이트
제3장 시장 개요
개요
첨단 약물전달 시스템의 진화
제4장 시장 역학
개요
시장 성장 촉진요인
시장 성장 억제요인
시장 기회
COVID-19의 시장에 대한 영향
제5장 시장 평가 : 기술별
기술 개요
시장 점유율과 예측
즉시 방출 약물전달
서방성 약물전달
표적 방출 약물전달
지연 방출 약물전달
펄스 방출 약물전달
제6장 시장 평가 : 투여 경로별
투여 경로 개요
시장 점유율과 예측
경구
비경구/주사
경점막
경점막 비 및 폐
경점막 눈
경점막 직장
경점막 구강점막
경점막 질
임플란트
경피
국소
제7장 시장 평가 : 비히클/캐리어별
세계의 첨단 약물전달 시스템 시장 : 비히클/캐리어별
시장 점유율과 예측
나노입자
단클론항체
리포솜
고분자 치료
덴드리머
고분자 약제
고분자 미셀
프로드러그
미립자
기타
제8장 시장 평가 : 용도별
세계의 첨단 약물전달 시스템 시장 : 용도별
시장 점유율과 예측
종양
염증성 질환·알레르기
심혈관
안과
중추신경계
호르몬 대체요법·부인과
바이러스성 질환·세균성 질환
당뇨병
비뇨기과
위장(GI) 질환
피부과
호흡기계
기타
제9장 시장 평가 : 지역별
세계의 첨단 약물전달 시스템 시장 : 지역별
북미
유럽
아시아태평양
기타 지역
제10장 ESG 전개
ESG : 서론
첨단 약물전달 시스템 업계의 지속가능성 : ESG의 관점
ESG의 주요 문제
ESG 리스크 순위
ESG에 대한 소비자 태도
사례 연구
BCC에 의한 결론
제11장 시장의 신기술
신기술
약물전달의 3D 프린팅 기술
생물학적 제제 약물전달
약물전달의 AI
스마트 약물전달 시스템
제12장 임상시험·특허 분석
제13장 경쟁 정보
시장 점유율 분석
주요 기업의 최근 동향
제14장 기업 개요
ABBOTT
ABBVIE INC.
ASTRAZENECA
BD
BOSTON SCIENTIFIC CORP.
F. HOFFMANN-LA ROCHE LTD
JOHNSON & JOHNSON SERVICES INC.
KINDEVA DRUG DELIVERY
MEDTRONIC
MERCK & CO. INC.
NOVARTIS AG
PFIZER INC.
SANOFI S.A.
TERUMO CORP.
TEVA PHARMACEUTICAL INDUSTRIES LTD.
제15장 부록 : 두문자어
ksm
영문 목차
영문목차
Highlights:
The global market for advanced drug delivery systems is expected to increase from $262.6 billion in 2023 to $359.1 billion by the end of 2028, with a compound annual growth rate (CAGR) of 6.5% during the forecast period of 2023-2028.
North American market for advanced drug delivery systems is expected to increase from $109.4 billion in 2023 to $152.1 billion by the end of 2028, with a CAGR of 6.8% during the forecast period of 2023-2028.
Asia-Pacific market for advanced drug delivery systems is expected to increase from $47.7 billion in 2023 to $68.6 billion by the end of 2028, with a CAGR of 7.5% during the forecast period of 2023-2028.
Report Scope:
This report aims to provide a comprehensive study of the global market for advanced drug delivery systems (ADDS) and processes, both in terms of quantitative and qualitative data, to help people and companies develop business/growth strategies, assess the market landscape, analyze their position in the current marketplace and make informed business decisions about drug deliveries.
This in-depth analysis of the global ADDS market includes historical data and market projections on sales by technology, route of administration, drug vehicles/carriers and application. The analysis describes the different types of ADDS technology (immediate-release drug delivery, extended-release drug delivery, targeted-release drug delivery, delayed-release drug delivery, and pulsatile-release drug delivery) and their current and historical market revenues. It also covers the route of administration of a drug delivery system and the source of a carrier mechanism for drug delivery. In addition, the report examines applications of ADDS (oncology, respiratory, inflammatory and allergies, cardiovascular, ophthalmic, central nervous system, hormone replacement therapy and gynecology, viral and bacterial diseases, diabetes, urology, gastrointestinal disorders, dermatology, other).
The geographic scope of this study covers the U.S. and companies worldwide. The report identifies the main elements of advanced drug delivery products and trends in different industries.
Report Includes:
27 data tables and 93 additional tables
An overview of the global markets and technologies for advanced drug delivery systems (ADDS)
Analyses of the global market trends, with historical market revenue data (sales figures) from 2021 to 2022, estimates for 2023, forecasts for 2024, and projections of compound annual growth rates (CAGRs) through 2028
Estimate of the market size and revenue forecast for the global ADDS market, and corresponding market share analysis based on technology, application (therapeutic area), route of administration, vehicle/carrier of drugs mechanism and geographic region
Facts and figures pertaining to the market drivers, opportunities and challenges, emerging technologies and regulatory landscape
Discussion of the importance of ESG in the ADDS market, including consumer attitudes, impact of ESG factors on company performance and ESG practices of leading companies
Review of patents and patent applications filed on drug delivery release mechanisms and novel applications
Insight into the emerging technologies and developments in the ADDS market and clinical trial landscape
An analysis of the industry structure, including company market shares, recent M&A activity and venture funding
Analysis of the competitive landscape based on recent developments and the segmental revenues of leading vendors
Company profiles of major players within the industry, including Johnson & Johnson, Novartis AG, Pfizer Inc., Merck & Co. Inc., Medtronic, and Abbott.
Table of Contents
Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
What's New in this Update?
Methodology
Information Sources
Geographic Breakdown
Segmentation Breakdown
Chapter 2 Summary and Highlights
Market Outlook
Highlights of the Market for Advanced Drug Delivery Systems
Chapter 3 Market Overview
Overview
Evolution of Advanced Drug Delivery Systems
Chapter 4 Market Dynamics
Overview
Market Drivers
Market Restraints
Market Opportunities
Impact of COVID-19 on the ADDS Market
Chapter 5 Evaluation of the Market Based on Technology
Overview of Advanced Drug Delivery Systems and Technologies
Market Share and Forecast
Immediate-Release Drug Delivery
Extended-Release Drug Delivery
Targeted-Release Drug Delivery
Delayed-Release Drug Delivery
Pulsatile-Release Drug Delivery
Chapter 6 Evaluation of the Market Based on Route of Administration
Overview of Routes of Administration of Drugs
Market Share and Forecast
Oral
Parenteral/Injectable
Transmucosal
Transmucosal Nasal and Pulmonary
Transmucosal Ocular
Transmucosal Rectal
Transmucosal Oral Buccal
Transmucosal Vaginal
Implant
Transdermal
Topical
Chapter 7 Evaluation of the Market Based on Vehicle/Carrier
Overview of Vehicles/Carriers Used in Advanced Drug Delivery Systems
Market Share and Forecast
Nanoparticles
Monoclonal Antibodies
Liposomes
Polymeric Therapeutics
Dendrimers
Polymeric Drug
Polymeric Micelles
Prodrugs
Microparticles
Others
Chapter 8 Evaluation of the Market Based on Application
Overview of Applications Used in Advanced Drug Delivery Systems
Market Share and Forecast
Oncology
Inflammatory Diseases and Allergies
Cardiovascular
Ophthalmic
Central Nervous System
Hormone Replacement Therapy and Gynecology
Viral and Bacterial Diseases
Diabetes
Urology
Gastrointestinal (GI) Disorders
Dermatology
Respiratory
Other Therapeutic
Chapter 9 Evaluation of the Market Based on Geographic Region
Global Market for ADDS by Region
North America
Europe
Asia-Pacific
Rest of the World (RoW)
Chapter 10 ESG Development
Introduction to ESG
Sustainability in the Advanced Drug Delivery Systems (ADDS) Industry: An ESG Perspective
